Carbonic anhydrase 7
Carbonic Anhydrase 7[edit]
Carbonic Anhydrase 7 structure
Carbonic Anhydrase 7 (CA7) is an enzyme that belongs to the carbonic anhydrase family. It plays a crucial role in catalyzing the reversible hydration of carbon dioxide (CO2) to bicarbonate (HCO3-) and a proton (H+). This enzyme is encoded by the CA7 gene, which is located on chromosome 16 in humans.
Structure[edit]
The structure of Carbonic Anhydrase 7 consists of a single polypeptide chain, which folds into a compact globular shape. It contains a zinc ion at its active site, which is essential for its catalytic activity. The enzyme has a molecular weight of approximately 30 kDa.
Function[edit]
Carbonic Anhydrase 7 is primarily expressed in the brain, specifically in the cerebellum and hippocampus. It is involved in maintaining the acid-base balance in these regions, as well as regulating the production of cerebrospinal fluid. Additionally, CA7 has been found to play a role in neuronal development and synaptic plasticity.
The catalytic activity of Carbonic Anhydrase 7 is crucial for the transport of carbon dioxide and bicarbonate across cell membranes. By converting CO2 into HCO3- and H+, it helps maintain the pH balance within cells and tissues. This process is particularly important in tissues with high metabolic activity, such as the brain.
Clinical Significance[edit]
Mutations in the CA7 gene have been associated with certain neurological disorders, including epilepsy and ataxia. These mutations can disrupt the normal function of Carbonic Anhydrase 7, leading to imbalances in pH regulation and impaired neuronal development.
Furthermore, Carbonic Anhydrase 7 has been identified as a potential therapeutic target for the treatment of glaucoma. Inhibition of this enzyme has shown promise in reducing intraocular pressure, which is a major risk factor for glaucoma.
References[edit]
<references />
See Also[edit]
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
- Budget GLP-1 shots
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian